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ABSTRACT 
The Polo like kinase (Plk) family members are critical regulators of cell cycle 
progression, mitosis, cytokinesis and the DNA damage response. While much is known 
regarding the phenotype associated with loss or overexpression of Sak, less than a 
handful of interacting partners/substrates are known. Therefore, the identification and 
characterization of Sak interacting partners will contribute to our understanding of the 
essential role of Sak in the cell. 
Our results show that Sak physically interacts with and co-localizes with Cyclin 
Bl. Furthermore, we identified Gadd45a as both an interacting partner and a substrate for 
Sak. The site of phosphorylation was putatively identified as TyrlSl on Gadd45a. In 
addition, we found that endogenous Sak protein levels are decreased in response to UV 
and that this decrease is p53-dependent. These findings suggest that Sak in addition to 
Sak playing a role in centrosome duplication that it may also function in mitotic entry and 
DNA damage response pathways. 
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Polo-like Family Function and Members 
The polo-like kinases (Plks) are a conserved subfamily of Ser/Thr protein 
kinases that play pivotal roles in regulating various cellular and biochemical events at 
multiple stages of cell cycle progression (Glover et al, 1998; Nigg, 1998; Dai et al, 
2003). They regulate cell cycle progression, including centrosome duplication, DNA 
damage response in S phase, Golgi dynamics in G2 phase as well as Mitotic entry, 
spindle assembly and cytokinesis in M phase. 
The founding member of this family, Polo, was originally identified in the 
fruit fly {Drosophila melanogaster) and was shown to be a serine-threonine kinase 
that is required for mitosis (Fenton and Glover, 1993). Lower eukaryotic organisms 
such as the budding yeast Saccharomyces cerevisiae and the fission yeast 
Schizosaccharomyces pombe have only one homolog of Polo, Cdc5 and Plol, 
respectively (Kitada et al, 1993; Ohkura et al, 1995). Higher eukaryotic organisms 
such as the Caenorhabditis elegans contains three Polo structural homologues (Plkl, 
Plk2 and Plk3) (Ouyang et al, 1999; Chase et al, 2000), while vertebrates have four 
Plk family members (Plkl, Plk2, Plk3 and Plk4/Sak) (Glover et al, 1998; Nigg, 
1998). The increase in number of Plk members in higher organisms is likely a 
reflection for the need of tighter controls on the cell cycle regulation. 
The Structure of the Polo-like Kinases 
All Plks share two conserved features: first, a Ser/Thr kinase domain in the 
amino-terminal region of these proteins which is critical for the various cellular 
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functions of the Plks; second a structural motif termed the Polo box domain (PBD) in 
the noncatalytic carboxyl-terminal region (Li et al, 1996; Elia et al, 2003a). The 
PBD plays important roles in both Plk localization and function. Mutation of the PBD 
of Plkl results in loss of Plkl localization to the spindle pole and the bud neck. 
Recent studies have also revealed that the PBD functions as a docking site for various 
serine/threonine phosphorylated proteins (Elia et al, 2003b; Lowery et al, 2004). The 
phosphopeptide-binding function of the PBD is intricately linked to how Plkl 
controls cell cycle progression through mitosis. Plks 1-3 share a common domain 
architecture consisting of an N-terminal kinase domain and two polo box domains at 
C-terminus. Sak/Plk4 differs from other polo-like kinases in that it has only a single 
polo box at C-terminus (Hudson et al. 2001; Leung et al. 2002; Swallow et al, 2005). 
This chapter mainly introduces the polo-like kinases in lower eukaryotes and 
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Figure 1. Polo-like kinase structure. Plkl-3 contain an amino-terminal kinase 
domain and two carboxy-terminal PBD. Sak/Plk4 differs from other polo-like 
kinases in that it has only a single polo box at the carboxy-termimis, while all 
other Plks have two. The kinase domain is represented by the yellow colour and 
the polo-box domains are showed in green colour. 
Plks Expression and Kinase Activity 
The Plk gene family are differentially expressed during normal cell cycle 
progression. In general, Plkl expression/activity is low in GO, Gl, and S, begins to 
increase in G2, and peaks in M phase (Roshak et al, 2000; Alvarez et al, 2001; 
Anger et al, 2003). Plk2 mRNA and protein is expressed in early Gl, has a fast 
turnover rate (half-life of B15 min) and is catalytically active (Ma et al, 2003b). This 
finding is consistent with the function of Plk2 as a regulator of Gl progression in 
mammalian cells (Ma et al, 2003a).The precise role of Plk3 in mammalian cells is 
not yet fully established, but it appears to be primarily involved in pathways involved 
in the cellular response to DNA damage (Barr et al., 2004). Maximum levels of Plk3 
mRNA expression are detected 1 h after FGF or serum stimulation of quiescent NTH 
3T3 cells, and expression decreases to basal levels by 8 h (Donohue et al, 1995). 
However, Plk3 protein levels remain relatively constant in mitogen stimulated NIH 
3T3 cells (Chase et al, 1998; Bahassi et al, 2002) 
The Plk family genes are also differentially regulated in stressed cells; for 
example, when DNA-damaging agents are added to cycling cells, Plkl expression 
decreases, but Plk2 and Plk3 expression increases. Furthermore, Plkl is expressed at 
the highest levels in tissues with actively proliferating cell populations; for example, 
the placenta (Wolfe/ al, 2000), spleen (Golsteyn et al, 1994), ovary (Takai et al, 
1999), and testis (Syed and Hecht, 1998). Plkl transcripts are either undetectable or 
present at very low levels in most other adult tissues, including the liver, kidney, brain 
and skin (Wolf e? al, 2000). The tissue distribution of Plk2 and Plk3 differ greatly 
from Plkl. Plk2 and Plk3 transcripts have a broad tissue distribution. Finally, Plkl, 2, 
3 are expressed to varying degrees in different human tissue types and it has been 
reported that Plkl expression is increased and Plk3 expression is decreased in tumor 
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specimens. Plk2 gene expression levels in human tumor specimens have not yet been 
reported (Winkles JA et al., 2005). 
The differential regulation of Plk family member gene expression indicates 
one cellular strategy for controlling Plk activity in mammalian cells. 
Plk Localization 
The localization of individual Plks is dynamically regulated during the cell 
cycle. Plk proteins from yeast to mammalian undergo apparent subcellular 
localization differences. In unicellular organisms such as yeasts, the Plks (Cdc5 and 
Plol) localize to the spindle pole bodies (SPBs) but with apparent differences in 
timing. Cdc5 localizes to the SPBs (Shirayama et al, 1998; Song et al.,2000) during 
early Gl and remains there until late mitosis, whereas Plol associates with the SPBs 
after the activation of Cdc2 (Cdkl) and dissociates from the SPBs as Cdc2 becomes 
inactive (Mulvihill et al, 1999). In addition, Cdc5 localizes to the septin ring 
filaments in G2 and remains until late mitosis (Sakchaisri et al, 2004), whereas Plol 
localizes to the medial ring structures at the time of their formation (Bahler et al, 
1998). The founding member of this family, Drosophila polo is present in 
centrosomes early in mitosis, accumulates around the nuclear envelope until its 
breakdown. During prometaphase, polo localizes to the kinetochores and at metaphase 
associates to spindle microtubules (Moutinho-Santos et al., 1999). 
Studies in cultured mammalian cells revealed that Plkl localizes to the 
cytoplasm and the nucleus during G2 and is specifically targeted to the centrosomes 
(Taniguchi E., 2002). During early mitosis, Plkl can be found at centrosomes and 
kinetochores (Golsteyn RM et al, 1995). In addition, a fraction of Plkl translocates to 
the midzone/midbody late in mitosis. Plk2 localizes to the centrosome, indicating a 
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role for Plk2 in centriloe duplication (Warnke et al, 2004). There are several 
conflicting reports about Plk3 localization in the literature. Plk3 has been reported to 
colocalize with the centrosome, the spindle pole and spindle microtubules (Wang Q et 
al.,), as well as with the Golgi apparatus (Ruan Q et al, 2004), and actin-containing 
plaques (Holtrich U et al, 1995, Wendy C et al. 2007) demonstrated that Plk3 
localizes in the nucleolus. 
The dynamic subcellular localization of Plk homologs suggests the functional 
complexity of these enzymes in various organisms. The apparent localization 
differences between yeast and mammalian Plks may reflect differences in the spatial 
and temporal regulation of the mitotic and cytokinetic machineries that these 
organisms utilize and the inherent need for greater controls in multicellular organisms. 
The Biological Functions of Plks 
Polo-like kinases play critical roles during multiple stages of cell cycle 
progression, they are important regulators for many cellular events critical for cell 
division including centrosome duplication and maturation, DNA damage checkpoint 
activation, mitotic onset, bipolar spindle formation, Golgi fragmentation and 
assembly, chromosome segregation, and cytokinesis. This review will focus on the 
roles of Plks in mitotic entry, mitotic exit and cytokinesis. 
i) Mitotic Entry 
In eukaryotic cells, initiation of mitosis requires nuclear translocation and 
activation of M-phase promoting factor (MPF); the complex of a Cyclin-dependent 
kinase Cdkl and the Cyclin B (Nurse, 1990; Hunt, 1991). Cyclin B accumulation, 
phosphorylation of Cdkl and intracellular localization of Cyclin Bl is regulated 
during the progression of the cell cycle (Pines, 1999; Yang and Kornbluth, 1999). 
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During S and G2 phases, Cyclin B accumulates and binds to Cdkl to form 
heterodimers. Cyclin B facilitates the inhibitory phosphorylation of Cdkl at Thrl4 
and Tyrl5, which are catalyzed by Weel, Mikl and Mytl kinases. At the end of G2, 
abrupt dephosphorylation of these sites by Cdc25 activates Cyclin B / Cdkl complex 
(Morgan, 1995; Nigg, 2001) which triggers mitotic entry. Recent studies have shown 
that Plkl acts as an important coordinator for MPF activation. Plkl promotes mitotic 
entry by activating Cyclin B/Cdkl at three different levels. (1) Plkl phosphorylates 
one member of the Cdc25 family of phosphatases, Cdc25C. Cdc25C is 
phosphorylated by Plkl in a nuclear export signal sequence during G2-M phase and 
this phosphorylation is necessary for the nuclear translocation and activation of 
Cdc25C during prophase.( Roshal AK et al, 2000; Toyoshima-Morimoto et al, 2002) 
Nuclear Cdc25C plays a role in keeping nuclear MPF active by counteracting the 
inhibitory activity of Weel, which is constitutively nuclear. (2) At the same time, 
Plkl phosphorylates the Cyclin B/Cdkl-inhibiting kinase Weel and Mytl (Watanabe 
N et al, 2004; Nakajima H et al, 2003), leading to enhanced association with the 
SCF/beta-TrCP E3 ubiquitin ligase, thereby inducing its degradation. (3) In addition 
to, it has been shown that Plkl phosphorylates Cyclin Bl at centrosomes, the first site 
at which CyclinB/Cdkl is activated and the phosphorylation triggers Cyclin Bl 
nuclear translocation during prophase (Toyoshima-Morimoto et al, 2001). During S 
and G2 phases, Cyclin Bl localized to the cytoplasm, where a subpopulation 
associated with microtubules. In late G2 phase, a fraction of CyclinBl was bound to 
the centrosomes, and at prophase, Cyclin Bl translocates into the nucleus. The 
nuclear accumulation of Cyclin Bl during prophase is thought to be important for 
initiating and coordinating M-phase events in vertebrate cells (Pines, 1999; Yang and 
Kornbluth, 1999; Takizawa and Morgan, 2000). 
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In Xenopus, Polo-like kinase Plxl plays an important role in initiating the 
G2/M transition. Data from the Xenopus system indicate that Plxl phosphorylates 
Cyclin Bl on Ser 101, This is supported by data indicating that Plkl phosphorylates 
Cyclin Bl on Ser 133 in human cells and Ser 147 in mammalian cells (Jackman et al, 
2003). This phosphorylation of Cyclin Bl initially occurs on centrosomes in 
prophase, and the phosphorylation does not cause Cyclin Bl to move into the nucleus 
(Jackman et al, 2003). It has been proposed that phosphorylated Cyclin Bl facilitates 
the interaction between Cdkl and Cdc25C (Peter et al, 2002). In this case, 
centrosomes may function as sites of integration for the proteins that trigger mitosis 
(Jackman et al, 2003). Furthermore, the studies carried out in Xenopus egg extracts 
and oocytes show that Plxl is the initial phosphorylating and activating kinase for 
Cdc25C in vivo and the activation of Cdkl/Cyclin B also requires the activation of 
Plxl as a trigger kinase to initiate Cdc25C activation (Qian et al, 1998a, 2001). In 
addition, Plxl and Cyclin B/Cdkl may act in a positive feedback loop ensuring 
complete activation of Cyclin B/Cdkl and mitotic entry (Alrieu A et al, 1998). 
Plk2 doesn't appear to play a role mitotic entry, it is identified as an early-
growth-response gene. Plk2 may primarily function as a regulator of Gl and early S 
phase progression, a time when both Plk2 mRNA and protein levels peak (Simmons 
DL etal, 1992; Ma S et al, 2003a). 
Plk3 is involved in regulation of the Gl/S phase transition and is required for 
entry into S phase (Wedy C et al, 2007). Recent studies have shown that Plk3 
phosphorylates Cdc25C on serine 191, and to a lesser extent serine 198, within the 
nuclear export signal (NES) to promote the nuclear accumulation of Cdc25C, and that 
substitution of serine 191 with an alanine abrogates Cdc25C's nuclear localization 
(Bahassi et al, 2004). Transient transfection of cells with wild-type Plk3 but not with 
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a kinase dead Plk3 results in a marked increase of Cdc25C in the nucleus. This 
nuclear accumulation of Cdc25C is inhibited when Plk3 is suppressed by siRNA, 
implicating the involvement of Plk3 in the nuclear accumulation of Cdc25C (Bahassi 
et al, 2004). 
Therefore, the Polo-like kinases act as important coordinators for intracellular 
localization of active MPF by directing nuclear entry of MPF and its activator 
Cdc25C, which may be essential for coordinating M-phase events. 
ii) Mitotic Exit 
In all eukaryotic organisms, exit from mitosis requires the inactivation of 
mitotic Cdkl activity, and this step is a prerequisite for the onset of cytokinesis. 
Unlike other eukaryotic organisms, downregulation of Cdkl activity in mammalian 
cells occurs at the metaphase/anaphase transition (Clute and Pines, 1999), while the 
inactivation of budding yeast Cdkl occurs after metaphase/anaphase transition 
(Ghiara et al, 1991; Surana et al, 1993), and it is achieved through the successive 
actions of two cooperative pathways termed FEAR (Cdc Fourteen Early Anaphase 
Release) network (Stegmeier et al, 2002) and MEN (Mitotic Exit Network) (Bardin 
and Amon, 2001; Jensen and Johnston, 2002). The FEAR and the MEN must be 
activated in an ordered manner, but how this order is maintained is not known. Both 
genetic and biochemical analyses showed that Cdc5 plays an important role in 
regulating both of these pathways and Cdc5 may coordinate these two pathways, 
perhaps by directly phosphorylating and regulating components in each pathway. 
Studies show that the Xenopus Polo-like kinase Plxl is required in mitotic 
exit. The metaphase to anaphase transition could be blocked by immunodepletion of 
Plxl, and was restored upon the addition of recombinant Plxl (Qian et al, 1999; Liu 
et al, 2004). These results demonstrate that the metaphase/anaphase transition 
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requires active Plxl. Furthermore, Plxl associates with the anaphase-promoting 
complex/cyclosome (APC/C). Studies so far have demonstrated three possible 
mechanisms that Plxl regulate APC/C activity. First, Plxl may activate APC/C by 
direct phosphorylation of several APC/C subunits (Kotani et al, 1998). The second 
mechanism may involve the regulation of APC/C activators or inhibitors by Plxl. 
Thirdly, Plxl is also required to prevent premature inactivation of the APC/C 
(Brassac et al, 2000). 
iii) Cytokinesis 
Polo-like kinases have been shown to play a role in cytokinesis, and much of 
the evidence came from studies on the fission yeast (Schizosacchromyces pombe 
(Ohkura et al, 1995; Bahler et al, 1998), Drosophila (Carmena et al, 1998), and 
more recently, the budding yeast {Sacchromyces cerevisiae) (Song and Lee, 2001). In 
budding yeast, besides the role in mitotic exit, Cdc5 is required for proper actin ring 
formation at the mother-bud-neck (Jimenez et al, 1998; Frenz et al, 2000; Lee et al, 
2001). Consistent with the role in cytokinesis, Cdc5 localizes to the neck as early as 
G2 and remains at this structure until late mitosis (Sakchaisri et al, 2004), suggesting 
of additional role(s) at the neck. Furthermore, depletion of Cdc5 results in arrests at 
multiple points during mitosis, suggesting a failure of cytokinesis (Song and Lee, 
2001). 
In fission yeast, loss of Plol function leads to the generation of multinucleate 
cells with defects in actin ring and septum formation, suggesting that Plol activity 
may be required for cytokinetic events. In early mitosis, Plol localizes to the future 
division site (Bahler et al, 1998; Mulvihill et al, 1999), and this localization appears 
to be important for the placement and organization of an actin-based medial ring 
(Bahler et al, 1998). Secondly, Plol activation correlates with the timing of septum 
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formation, which is regulated by a signaling network termed septation initiation 
network (SIN) (Bardin and Anion, 2001; McCollum D, 2001; Gruneberg and Nigg, 
2003). The SIN in fission yeast is composed of proteins structurally related to those in 
the MEN and they function at each tier of the pathway. In addition, in the absence of 
Plol activity, formation of a division septum is impaired in fission yeast, whereas 
overexpression of Plol leads to formation of an ectopic septum. 
In Drosophila, it was shown that Polo kinase and Pav-KLP 
coimmunoprecipitate, and they co-localize in the central part of the spindle. The Pav-
KLP family of motor proteins play a conserved role in organizing the central spindle 
in anticipation of cytokinesis. Furthermore, cytokinesis can fail at all stages of 
spermatogenesis in polo mutants (Carmena et al, 1998). Also, the Drosophila Polo 
was found to interact with CHOI homolog Pavarotti, which is implicated in 
cytokinesis (Adams RR et al, 1998). In Xenopus, Plxl has been shown to play a role 
in cytokinesis. Similarly, Plxl is localized to the midbody in late mitosis in Xenopus 
embryos (Qian et al, 1999). Interestingly, the inactivation of Plxl may also be 
required for completion of cytokinesis in Xenopus embryos (Qian et al., 1999). It 
seems that the initiation of cytokinesis requires the activity of Plks, and the 
completion of cytokinesis requires their inactivation or degradation. 
Mammalian Plkl has also been implicated in cytokinesis, consistent with Plk 
localization to the midzone late in mitosis. The first evidence of the involvement of 
Plkl in cytokinesis was the identification of the kinesin-like protein CHOl/MKLP-1 
as an in vitro substrate of Plkl, which induces microtubule bundling and antiparallel 
movement in vitro (Lee KS et al., 1995). On the other hand, overexpression of Plkl 
does give rise to multinucleated cells (Mundt KE et al, 1997), indicating the precise 
level of Plkl may be important for the correct execution of cytokinesis. Evidence for 
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a role for Plkl in cytokinesis was also found in overexpression studies with a 
dominant negative mutant of Plkl, which causes a failure in completion of cytokinesis 
after forced inactivation of the spindle assembly checkpoint (Seong YS et al, 2002). 
In addition, Plkl has been found to phosphorylate several other proteins that are 
involved in cytokinesis, like NudC, a component of the dynactin complex (Zhou T et 
al, 2003). MKlp2, a kinesin localized to the midbody in cytokinesis (Neef R et al, 
2003). Finally, the Rho exchange factor ECT2 is another Plkl substrate recently 
implicated in cytokinesis (Niiya F et al, 2005). 
These observations strongly suggest that Plks play a role in both the 
organization of the central spindle and the correct execution of cytokinesis. 
The Polo Box Domain 
In Plks 1-3, studies have shown that the PBD made up of polo box 1 (PB1) 
and polo box 2 (PB2) motifs, a linker of 20 residues and 45 residues upstream of PB1 
is a functional domain of approximately 80 amino acids (Cheng et al, 2003), It 
consists of a continuous six-stranded antiparallel p-sheet and an a-helix. The PBD 
regulates the cellular function of the Plks, subcellular localization and substrate 
interactions (Seong YS et al, 2002; Elia AE et al, 2003; Reynolds N., 2003). It is 
thought to localize the respective kinase to various mitotic structures during cell cycle 
progression, including centrosomes in early M phase, the spindle midzone in early 
and late anaphase and the midbody in cytokinesis, presumably to promote interaction 
between its catalytic domain and specific substrates and effectors (Lee et al, 1998; 
Jang et al, 2002a). For example, Polo-like kinases have been shown to interact with 
Cdc25C (Kumagai and Dunphy, 1996; Ouyang et al, 1999), and this interaction is 
polo box-dependent (Elia et al, 2003b). Mutation of the putative Plkl pThr-binding 
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motif in Cdc25C indeed abolishes interaction between Cdc25C and the Plkl-PBD, 
and decreases phosphorylation of Cdc25C (Elia et al, 2003).Furthermore, residues 
Trp-414, Val-415 and Leu-427 in PBD all contribute to proper Plk localization and 
function in various Plk family members, including budding yeast Cdc5, fission yeast 
Plol, murine Plk and human Plkl.Trp 414 in PB1 of human Plkl has been suggested 
to play a critical role in PBD substrate binding (Elia et al, 2003b). Mutation of this 
residue to phenylalanine dramatically affects the ability of human Plkl to complement 
the Cdc5-1 defect in yeast and disrupts Plk localization at spindle poles and septin 
ring structures (Lee et al, 1998). Mutation of the residue analogous to Trp-414 in 
Xenopus Plxl and Val-415 in budding yeast Cdc5 inhibits interaction with substrates, 
such as the APC/C subunit Cdc27 (Liu J et al, 2004). In addition, Plxl function in 
bipolar spindle formation (Qian et al, 1998a) has also been demonstrated to be polo 
box dependent (Liu et al, 2004). Studies identified that the optimal sequence motif 
recognized by the PBD is Ser-[pSer/pThr]-[Pro/X], suggesting that Cdks, MAP 
kinases, and other mitotic kinases might generate 'priming' phosohorylations on 
substrates or docking proteins to localize Plks in the vicinity of their substrates (Elia 
et al, 2003). At present, verified in vivo Plkl substrates include Cdc25C (Toyoshina 
Morimoto et al, 2002), Brca2 (Lin et al, 2003), Myl(Nakahjima et al, 2003), Cyclin 
B (Toyoshima-Morimoto et al, 2001), NudC (Zhou et al, 2003), Nip (Casenghi et 
al, 2003), TCTP (Yarm, 2002), Mklpl (Lee et al, 1995; Liu et al, 2004), Chk2 
(Tsvetkov et al, 2003), MKIp2 (Neef et al, 2003), and Weel (Sakchaisri et al, 2004; 
Watatnabe et al, 2004). All of these contain potential PBD-binding sites. Other 
substrates of the Plk family members have been identified are summarized and listed 
in Table 1. 
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Plks and Centrosomes 
Centrosomes are the microtubule-organizing centers (MTOC) and are 
important for the formation of the bipolar spindle during mitosis. They contain a pair 
of microtubule-based centrioles and surrounding pericentriolar material. The 
centrioles duplicate once during the cell cycle to give rise to two mitotic spindle 
poles. So, cells normally contain one or two centrosomes depending on their phases in 
the cell cycle. Centrosome duplication starts at later Gl phase and proceeds through S 
phase (Fukida S et al, 2002). Prior to mitosis, the duplicated centrosomes separate 
and move to the future poles of the spindle to initiate the bipolar spindle, this is 
required for equal segregation of chromosomes. Duplication of a single centrosome 
must be precisely coordinated with the duplication of the genome to ensure faithful 
transmission of genetic material. Aberrant centrosome numbers can result in the 
generation of monopolar and multipolar spindles. Centrosome abnormalities are 
implicated in chromosomal instability and in the development of cancer, and many 
cancer cells display multiple centrosomes or enhanced centrosomal activity (Li et al, 
2001). Extent research has indicated that polo-like kinases family plays a pivotal role 
in the regulation of the centrosome duplication and maturation (Glover et al, 1996; 
Wiannyefa/., 1998). 
In budding yeast, Cdc5, a homologue of the Plks is required for spindle pole, 
the functional counterparts to centrosomes, and for the formation of normal mitotic 
spindles. The evidence indicating a role for Cdc5 in regulating the spindle pole body 
(SPB) came from the study of meiosis I in budding yeast (Schild and Byers, 1980). A 
temperature-sensitive mutant of Cdc5 fails to complete meiosis I due to arrest at a 
stage after SPB duplication and separation at the restrictive temperature. In these 
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mutant cells, SPBs lack the normal spindle microtubules that are characteristic of 
meiosis I in wild-type cells. 
In fission yeast, Plol is required for the assembly and function of the mitotic 
spindle. Both loss of Plol function and over-expression of this gene results in 
formation of cells in which condensed chromosomes are associated with monopolar 
spindles (Ohkura et al, 1995), indicating a failure in bipolar spindle formation. 
In Drosophila, embryos from homozygous polo females display abnormal 
spindles which are multiple branched spindles in syncytial polo-derived embryos, 
spindles with broad poles and fewer circular mitotic figures in larval neuroblasts 
(Sunkel and Glover, 1988). While in strongly hypomorphic mutants (polo9/10), a 
majority of cells are arrested in a metaphase-like stage lacking asters at each spindle 
pole and they all possess bipolar spindles with robust arrays of microtubles 
(Donaldson et al, 2001). 
In embryonic Xenopus cells, Plxl is localized to mitotic spindles. In early 
prophase, Plxl has a bipolar localization at the spindle poles and colocalizes with y-
tubulin. Inhibition of Plxl by microinjection of anti-Plxl antibodies into Xenopus 
embryos resulted in monopolar spindles with altered patterns of a-tubulin associated 
with a radial distribution of chromosomes around the pole (Qian et al, 1998a). The 
exact mechanism by which Plxl regulates bipolar spindle formation is not clear. 
However, evidence from studies in mammalian cells suggests that Plxl most likely 
affects bipolar spindle formation by regulating both centrosome separation and 
maturation. It is therefore likely that Plxl regulates centrosome separation and 
maturation by recruiting specific proteins necessary for these processes to 
centrosomes. 
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Several mammalian Plks are involved in regulating centrosomal function 
although the molecular basis of their roles remains unclear. Plkl was first implicated 
in the centrosome cycle because of its centrosomal localization during interphase and 
its association with mitotic spindle poles in early mitosis (Golsteyn et al, 1994). Plkl 
antibody injection studies show that Plkl is also essential for centrosome separation, 
with defects leading to monopolar spindles and consequent mitotic arrest (Lane HA et 
al, 1996). Plkl depletion by siRNA significantly reduced centrosome amplification 
(Liu and Erikson, 2002). Plkl interacts and phosphorylates a-, p- and y-tubulins and 
the tubulin-atabilizing protein TCTP (Feng Y et al, 1999; Yarm FR et al, 2002), 
indicating that Plkl may regulate spindle formation through centrosome maturation 
and separation as well as by directly regulating tubulin functions. 
Plk2 also plays an important role in the reproduction of centrosomes. The 
study showed that the polo-box of Plk2 is required for the centrosome and centriole 
duplication. Mutation of Plk2 polo-box impairs centrosomal localization and centriole 
duplication. Plk2 is localized to centrosomes during early Gl phase and only 
associates to the mother centriole. Furthermore, the results suggest that Plk2 mediated 
centriole duplication is dependent on Sak function. In addition, the downregulation of 
Plk2 leads to abnormal mitotic spindles, indicating that Plk2 may have a function in 
the reproduction of centrioles (Cizmecioglu O et al, 2008). 
Plk3 primarily localizes to the microtubule organization center during 
interphase. In all stages of the cell cycle Plk3 is associated with centrosomes or 
mitotic spindle poles (Wang et al, 2002). It remains unclear why both Plkl and Plk3 
are localized to centrosomal regions during interphase. Thus, Plks may fulfill different 
functions in regulating microtubule dynamics during the cell cycle. 
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Plks and DNA Damage Checkpoint Pathways 
The progression of the cell cycle is tightly regulated in order to maintain 
genetic integrity and to ensure that genetic information is correctly passed on to 
daughter cells. Surveillance mechanisms, known as checkpoints monitor the integrity 
of cell cycle progression (Elledge, 1996). The checkpoints are activated in response to 
DNA damage caused by environmental stress and /or internal perturbations. Various 
types of DNA damage activate DNA damage checkpoint pathways that arrest cells at 
the Gl/S border (Gl-phase checkpoint), delay S-phase progression (intra-S-phase 
checkpoint), or prevent mitotic entry (G2-phase checkpoint), depending on the phase 
of the cell cycle in which the damage occurs. DNA damage induces several cellular 
responses including DNA repair, checkpoint activity and the triggering of apoptotic 
pathways depending on the severity of the damage and the cell context. 
Cell cycle regulatory proteins are targets and effectors of DNA damage 
checkpoint pathways. Two protein kinases, ATM (ataxia telangiectasia mutated) and 
ATR (ataxia telangiectasia and Rad-3-related) are at the top of signaling cascades that 
transmit the signals downstream to mediators (Chkl and Chk2) and effectors (p53, 
p21, Cdc25A, Cdc25C). Polo and Polo-like kinases have emerged as major regulators 
for various cell cycle checkpoints. Extensive research has demonstrated that the Plks 
are important mediators for various cell cycle checkpoints that monitor centrosome 
duplication, DNA replication, formation of bipolar mitotic spindle, segregation of 
chromosomes, and mitotic exit, thus protecting cells against genetic instability during 
cell division (Nigg, 1998; Dai et al, 2002; Barr et a!., 2004). In response to DNA 
damage, budding yeast arrests in metaphase with active Clb-Cdc28, but eventually 
continues through the cell cycle even if the damage is not repaired. However, a 
mutation in CDC5 (cdc5-ad) completely eliminates the ability of these cells to over-
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ride cell cycle arrest even in the presence of an irreparable double-strand DNA break 
(Toczyski et al, 1997), suggesting a role for Cdc5 in overriding the DNA damage 
checkpoint (Sanchez et al, 1999). It remains to be determined how Cdc5 
downregulates the DNA damage checkpoint pathway and what it targets for 
adaptation. 
Several studies show that the activity of Plkl is inhibited after DNA damage 
(Smits et al, 2000; van Vugt et al, 2001; Ando et al, 2004). However, expression of 
activation mutants of Plkl can override the G2/M arrest induced by DNA damage 
(Smits et al, 2000). In addition, Plkl can bind to p53 which plays an important role in 
maintaining genomic fidelity by controlling cell cycle checkpoints and apoptotic 
process in response to genotoxic stress (Levine, 1997). Plkl inhibits p53 
transactivation activity and its pro-apoptotic function, whereas the kinase-deficient 
mutant form of Plkl failed to reduce the transcriptional activity of p53. Besides, Plkl 
and Chk2 have been shown to colocalize at centrosomes in early mitosis and to the 
mid-body in late mitosis (Tsvetkov et al, 2003). Plkl also interacts with and 
phosphorylates Chk2 (Tsvetkov L et al, 2003). Overexpression of Plkl enhances 
phosphorylation of Chk2 at T68 (Tsvetkov et al, 2003), a site primarily targeted by 
ATM in response to ionizing radiation, leading to its activation (Matsuoka et al, 
2000). Another substrate of Plkl involved in the DNA damage checkpoint is the 
breast cancer susceptibility protein, BRCA2, which is essential for the repair of DNA 
double-strand breaks (Lin HR et al, 2003; Lee M et al, 2004). Plkl phosphorylates 
BRCA2 during mitosis (Lin et al, 2003; Lee et al, 2004). The phosphorylation of 
BRCA2 is inhibited by DNA damage, which is consistent with the finding that Plkl 
activity is negatively regulated by DNA damage (Smits et al, 2000). Therefore, after 
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DNA damage, the activity of Plkl is inhibited, leading to activation of p53 and 
modulation of Chk2 and BRCA2. 
Other mammalian Plks are also involved in the DNA damage checkpoint 
activation pathway. Expression of Plk2 mRNA is rapidly induced upon X-ray 
irradiation; Plk3 kinase activity is activated upon oxidative stress and DNA damage 
induced by ionizing-radiation mimetic drugs, and its activation is ATM-dependent 
(Xie et al, 2001a, b). Plk3 interacts with and phosphorylates p53; targeting serine-20 
of p53 in vitro (Xie et al, 2001b) and the extent of this interaction is increased in 
response to DNA damage (Xie et al, 2001b). Plk3 also physically interacts and 
phosphorylates with Chk2 during DNA damage checkpoint activation (Bahassi et al, 
2002). Together, these studies suggest that Plk3 functionally links DNA damage to 
the induction of cell cycle arrest or apoptosis. Furthermore, Plkl is inhibited in 
response to DNA damage, Plk3 is activated suggesting that both kinases have 
opposing roles in checkpoint control (Xie et al, 2001). 
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Figure 2. Major pathways where Plks may play a role in checkpoint in 
mammalian systems. Arrows and bars denote the positive and negative regulations, 
respectively. Dotted lines denote where the regulatory role in vivo between these 
proteins remains to be elucidated. 
PIks and Oncogenesis 
Polo-like kinases play an important role in the centrosome cycle. Mutations of 
Plks from Polo, CDC5, Plol to Plkl, Plk2, Plk3 resulted in aberrant centrosome 
numbers. Centrosome abnormalities are implicated in chromosomal instability and in 
the development of cancer. Extensive studies have shown that deregulated expression 
of Plks is detected in many types of cancer and is associated with oncogenesis. 
Plkl expression is elevated in non-small-cell lung cancer (Wolf et al, 1997), 
head and neck cancer (Knecht et al, 1999), esophageal cancer (Tokumitsu et al, 
1999), melanomas (Strebhardt et al, 2000), breast cancer (Wolfe? al, 2000), ovarian 
cancer (Takai et al., 2001a), endometrial cancer (Takai et al, 2001b), colorectal 
cancer (Macmillan et al, 2001), gliomas (Dietzmann et al, 2001), and thyroid cancer 
(Ito et al, 2004). Results from these studies indicate that overexpression of Plkl is 
positively correlated with aggressiveness and prognosis in many cancers. Moreover, 
inhibition of Plkl with various techniques results in growth arrest or apoptosis for the 
cancer cells. Thus, Plkl could be a novel prognostic marker and a good target for 
chemotherapeutic intervention. The link between Plkl and oncogenesis may be due 
to several interacting partners of Plkl that are encoded by tumor suppressor genes. It 
has been reported that Plkl is able to phosphorylate the p53 protein in vitro (Xie et 
al, 2001). Over 50% of human cancers contain mutations in the gene coding for p53. 
Plkl also phosphorylates the breast cancer susceptibility protein BRCA2 during 
mitosis, BRCA2 (Breast Cancer Type 2 susceptibility protein) is a human gene that is 
involved in the repair of chromosomal damage and belongs to tumor suppressor 
genes. The phosphorylation of BRCA2 is inhibited by DNA damage which can cause 
an increased risk for breast cancer. Chk2 (checkpoint kinase2) that is implicated in 
DNA repair processes, is also considered as a tumor suppressor protein. It has been 
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showed that Plkl can phosphorylate Chk2 at Thr-68, a site that is phosphorylated by 
ATM. ATM and ATM- and Rad3 related (ATR) are two tumor suppressor proteins 
with phosphotransferase activity. ATM plays a very important role in the linkage of 
DNA damage and the induction of a subsequent cell cycle arrest (Zhou and Elledge, 
2000). DNA damage activated ATM positively regulates the activation of other 
checkpoint kinases, like Chkl and Chk2 (Matsuoka et al, 2000), and phosphorylates 
p53, MDM-2 and BRCA1 (Khosravi et al, 1999). At the G2-DNA damage 
checkpoint inhibition of Plkl activity depends on ATM/ATR activity (van Vugt et al, 
2001). Taken together, Plkl interacts with several tumor suppressor proteins. On the 
one hand, Plkl phosphorylates p53, Chk2 and BRCA2 possibly to promote mitotic 
progression. On the other hand, Plkl is inhibited by tumor suppressor proteins like 
ATM, ATR, BRCA1 and Chkl. 
Plk2 may primarily function as a regulator of Gl progression in mammalian 
cells (Ma et al, 2003a). Plk2 is transcriptionally regulated by p53 (Burns et al, 2003) 
and expression of Plk2 is induced in a p53-dependent manner after DNA damage 
(Burns et al, 2003). Silencing of Plk2 by siRNA was followed by an increase in 
apoptosis. 
Several studies have examined Plk3 expression in human tumor specimens. 
Plk3 expression levels are downregulated in lung tumor specimens compared with the 
normal tissue (Li et al, 1996). Also, Plk3 mRNA downregulation has been detected 
in uterus (Ando et al, 2004), bladder (Ando et al, 2004), and head and neck 
squamous cell carcinoma (Dai et al, 2000) specimens. In summary, Plk3 gene 
expression appears to decrease during the development of some, but not all, types of 
tumors. Since Plk3 may primarily function in the DNA damage response pathway, 
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Sak (also called Plk4) was the last member of the polo-like kinase family to be 
identified in vertebrates. Similar to the other Plks, Sak has a kinase domain at its N-
terminus; however Sak appears to have diverged significantly from a primordial Plk 
early in the radiation of metazoans (Fode et al., 1994). The kinase domain of murine 
Sak is followed by 660 amino acids containing a single 64 amino-acid PBD at the 
COOH end. The Sak-pb is equally related by phylogenetic comparison to the pbl and 
pb2 domains of other Plks. The polo box domain functions as a docking site for 
various phosphorylated proteins. The C-terminus of Sak contains 3 PEST sequences, 
which are commonly associated with reduced protein stability. And Sak protein 
displayed a short half life (2-3 h) in nonsynchronized cells (Fode et al., 1996). The 
removal of PEST sequences from Sak enhances the stability of the protein (Yamashita 
et al., 2001). The upstream region of the Sak-pb domain is designated the 'cryptic 
polo box' (cry-pb) (Sak596-836) which binds to the Tec tyrosine kinase and stabilizes 
the protein by protecting it from PEST-dependent proteolysis (Yamashita et al., 
2001). Like the other Plks, Sak has been shown to be a functional kinase with known 
substrates including p53 (Ko et al, 2005; Swallow et al 2005), Handl (Martindll et al. 
2008), Cdc25C (Bonni et al. 2008) and Chk2 (Petrinac et al. in press 2009). Sak 
kinase activity is markedly increased by a SakT170D mutation in the T loop, while 














Figure 3. Structural features of Sak. Sak has a Ser/Thr kinase domain at the 
amino-terminus, a single PB motif at the carboxy-terminus, and three PEST 
destruction motifs. The conserved ATP-binding domain with the required Lys41 
residue and the T-loop activation domain with the required Thrl70 are indicated. The 
cry-pb interacts with the Sak kinase domain. 
Sak Expression and Localization 
Sak mRNA expression is relatively low in both quiescent, GO phase cells and 
in early-to-mid-Gl phase cells and then increases beginning in the late Gl phase, then 
increases in S through G2 phase, and peaks in M phase. This expression pattern is 
consistent with the mitotic functions of Sak (Winkles JA et al., 2005). Whether Sak 
protein levels and kinase activity are regulated in a similar manner is presently 
unknown. However, it was reported that Sak expression is associated with mitotic and 
meiotic cell division in mouse tissues (Fode C et al, 1994). Sak gene expression in 
mammalian cells is also controlled at the post-transcriptional, protein degradation 
level. Sak protein is ubiquitinated and destroyed at M phase by the APC/C (Fode C et 
al., 1994), similar in this regard to Cdc5 (Shirayama et al, 1998). 
Sak mRNA expression has been detected in only a few adult tissues by 
Northern blot hybridization analysis. In the mouse, Sak mRNA was found at the 
highest level in the testis, a tissue containing actively dividing somatic and germ cells, 
at an intermediate level in the spleen and thymus, and not at all in the brain, heart, 
kidney, liver, or ovary (Fode et al, 1994). 
The subcellular localization of epitope-tagged Sak is different from that of 
endogenous Sak. It is reported that GFP-Sak localized to the nucleolus in G2 and to 
centrosomes in early M phase (Hudson et al. 2001). During anaphase, GFP-Sak 
appeared to be dispersed throughout the cell, and at telophase the fusion protein was 
localized to the midbody cleavage furrow. Perinuclear localization of GFP-Sak was 
observed in interphase cells (Hudson JW et al, 2001). This is in contrast to 
observations of endogenous Sak which was found to associate with centrosomes 
throughout the cell cycle, as indicated by its co-localization with centrin, C-Napl and 
y-tubulin (Habedanck R et al, 2005). Interestingly, a recent study showed that both 
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endogenous Sak and ectopic GFP-Sak localizes nucleolar in Rcho-1 cells 
synchronized in G2/M following nocodozole treatment and endogenous Sak localizes 
to a single nucleolus, whereas a GFP-Sak fusion protein is ectopically localized to 
multiple nucleoli (Martindill DMJ et al, 2007). 
Sak Null Mice 
To study the role of Sak in embryonic development, a Sak null allele was 
generated. The murine Sak null phenotype was found to be embryonic lethal with 
embryos arresting at E7.5. Sak null embryos display a marked increase in mitotic and 
apoptotic cells. In addition, many of these cells are in late anaphase or telophase with 
abnormally high levels of Cyclin Bl and phosphorylated histone H3. This suggests 
that Sak is essential for exit from mitosis and cell viability (Hudson et al, 2001). 
Sak and Centrosomes 
The observation that endogenous Sak localizes to centrosomes led to further 
functional studies on Sak function which indicate a key role for Sak in centriole 
duplication. Interestingly, overexpression of wildtype Sak in U2-OS and HeLa cells 
resulted in a multiplication of Sak-positive signals which co-localize with centriole 
markers (Habedanck R et al, 2005). Downregulation of Sak in Drosophila cells by 
mutation leads to loss of centrioles (Bettencourt-Dias M et al, 2005). Furthermore, 
depletion of Sak, but not Polo, leads to the generation of cells with a reduced number 
of centrioles. Centriole loss in a cycling population of cells can arise through 
defective centrosome duplication, abnormal separation of centrosomes at entry to 
mitosis, or abnormal centrosome segregation to the daughter cells in cytokinesis 
(Bettencourt-Dias M et al, 2005). In addition, antibody-microinjection demonstrates 
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that suppression of Sak function interferes with centrosome overduplication. When 
HeLa cells were transfected with siRNA duplexes that targeted Sak, after depletion of 
Sak for 24 h, the vast majority of cells still exhibited bipolar spindles. However, after 
48 h, many monopolar spindles were observed. The results demonstrate that cells 
depleted of Sak undergo a step-wise loss of centrioles through the cell cycle, 
indicating that Sak is indispensible for centriole duplication (Habedanck R et al, 
2005). 
Cyclin-dependent kinase 2 (Cdk2) is localized to centrosomes and has 
previously been implicated in the regulation of centriole duplication in different 
species (Lacey KR et al, 1999). Overexpression of Sak cannot cause centrosome 
amplification in the absence of Cdk2 activity. Conversely, Cdk2 is not able to cause 
centrosome overduplication in the absence of Sak, indicating that Sak acts in 
cooperation with Cdk2. This shows that Sak is not the sole regulator of centriole 
duplication and further work need to unravel the integration of the Sak pathway with 
cell-cycle control of centrosome duplication. 
Both gain- and loss-of-function experiments demonstrate that Sak is required 
for the precise reproduction of centrosomes during the cell cycle. These observations 
strongly support a model in which Sak is a crucial regulator of centriole duplication in 
human and Drosophila cells. 
Sak and Cell Cycle Damage Pathways 
The activation of the Cdc25 and the p53 affects at least three stages at cell 
cycle: the Gl/S transition, S phase progression and the G2/M boundary (Samuel T et 
al, 2002; Latonen L et al, 2005). Sak was identified as a p53 target gene and was 
shown to be repressed by p53. Furthermore, Sak interacts and phosphorylates Cdc25C 
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which is one of the three members of the Cdc25 family of phosphatases in 
mammalian cells. The Cdc25 phosphatases function as key regulators of the cell cycle 
during normal eukaryotic cell division and as mediators of the checkpoint response in 
cells after DNA damage (Busch C et al., 2007). Cdc25C is active at the late G2-phase 
of the cell cycle. Sak has also been showed to interact with ATM, ATR, Chkl and 
Chk2 (Petrinac MSc thesis; Petrinac et al, in press 2009) and to phosphorylate Chk2 
(Petrinac et al, in press 2009) Therefore, these findings suggest that Sak may be an 
intermediate in the pathways regulating DNA damage responses and checkpoint 
arrest. 
Sak and Mitosis 
Sak may primarily play a role in M phase progression (Hudson et al, 2001) 
and this possibility is supported by data demonstrating Sak mRNA expression is 
relatively high in the G2, and M phases. A proposed role for Sak in mitosis is 
supported by the observation that Sak phosphorylates Cdc25C (Bonni et al, 2008). 
Cdc25C which regulates the activity of the mitosis promoting factor Cyclin B/Cdkl 
by dephosphorylation, thus triggering G2/M transition. Additionally, both the Sak null 
mouse model and cells derived form the Sak mouse support a role for Sak in mitosis 
and mitotic exit (Hudson JW et al, 2001). Null embryos display cells in late anaphase 
or telophase that continue to express Cyclin Bl and phosphorylated histone H3. 
Normally during normal mitotic progression Cyclin Bl and phosphorylated histone 
H3 are lost during the metaphase to anaphase transition. This implicates Sak with a 
role in chromosomal segregation and exit from mitosis (Hudson JW et al, 2001). 
Sak and Cancer 
30 
The Sak gene is found on Mouse-Chromosome 3 and Human- Chromosome 
4q28. A region frequently undergoes rearrangement or loss in human cancers 
(Hammond et al, 1999). Sak heterozygous mice are fertile. However, at age of 18-24 
months, Sak +" mice developed apparent tumors at the liver and the lung, suggesting 
that reducing levels of Sak are associated with tumor formation. The lesions of 
heterozgyous mice liver were primary liver carcinoma, which were typically 
multifocal (Ko et al. 2005). Additionally, studies suggest that Sak kinase regulates 
both Cdkl and APC/C and, thereby, entry into and exit from mitosis (Ko MA et al., 
2005). Cyclin Bl, phosphorylated Cdkl and securin levels were reduced in Sak+A 
livers after partial hepatectomy, consistent with a delay in reaching anaphase (Ko MA 
et al., 2005). Sak RNA and protein expression were retained in both spontaneous and 
partial hepatectomy-induced tumors, suggesting that the increased incidence of 
hepatomas in Sak+/~ mice resulted from haploinsufficiency and that Sak gene dosage is 
important to suppression of carcinogenesis. Murine embryonic fibroblasts (MEFs) 
derived from Sak +" mice have an about 2 fold greater doubling time compared to 
Sak+/+ MEFs which suggests that the heterozygous Sak MEFs are haplo-insufficient 
for cell cycle progression. 
Furthermore, Sak overexpression may also play a role in tumourigenesis. It 
has been reported that Sak is overexpressed in colorectal tumors (Eckerdt F et al., 
2005). Overexpression of Sak leads to multimucleation (Habedanck R et al, 2005). 
Increased centrosome number leads to genomic instability which in turn can 
contribute to oncogenic transformation. 
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Objectives of this Study 
While there is a considerable amount of information regarding the phenotypes 
associated with Sak overexpression and depletion in centrosome duplication, 
development and tumourigenesis, little is known regarding Sak interacting partners 
and potential substrates. Kinases in general tend to be promiscuous, targeting and 
interacting with numerous other proteins, however, less than a handful of Sak targets 
have been established. The Plks, in general, often interact with and target the same 
proteins or components of the the same cellular pathways; thus placing these 
proteins/pathways under tighter or opposing control. Therefore, the objective of the 
current investigation was to identify interacting partners and substrates for Sak. In 
order to accomplish this, an approach was employed in which known interacting 
partners for other Plks or proteins known to localize and effect similar cellular 
functions as Sak were tested as candidates for interaction. 
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CHAPTER III 
MATERIALS AND METHODS 
Preparation Escherichia coli (E. coli) Competent Cells 
Top 10 F Pilus E. coli cells from the frozen glycerol stock were streaked out 
onto LB agar plates, the plates were incubated at 37°C for overnight, then a single 
colony was picked and inoculated a starter culture of lOmL TYM medium which was 
incubated for approximately 16 hours at 37°C with vigorous shaking (approx. 
250rpm). lmL of starter culture was added to lOOmL prewarmed TYM media and 
cells were grown in 37°C shaker, OD600 was measured every 45 minutes-lhour until 
OD600 equaled 0.5(log phase growth), then the cultures were placed on ice with 
gently swirling for 5 minutes until cold. The culture was transferred to a sterile 
250mL centrifuge tube and centrifuged at 4000 rpm for 10 minutes at 4°C, then 
decant the supernatant and the pellet was resuspended in 30mL cold TfBI buffer 
gently using chilled pipettes. The cells were again centrifuged at 4°C for 10 minutes at 
4000 rpm and the supernatant was carefully discarded. The pelleted cells were 
resuspended in 4mL ice-cold TFBII buffer and lOOuL aliquots were quickly placed 
into sterile microcentrifuge tubes. The aliquots were frozen in liquid nitrogen and 
stored at -80°C. 
Transformation and DNA Purification 
Plasmid DNA was amplified in competent cells in order to obtain sufficient 
plasmid DNA needed for subsequent experimental procedures. Competent E. coli 
cells (Top 10 F Pilus) were thawed and kept on ice to ensure high transformation 
efficiency, 0.5-lug of DNA was added to lOOuL of competent cells and mixed gently 
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by pipetting up and down, then the cells were incubated on ice for at least 30 minutes, 
after this, the cells were heat shocked at 42°C for 40 seconds and then immediately 
place tubes on ice for 2 minutes. 500uL of LB medium was then added and the cells 
were incubated for 45 minutes at 37°C. IOOUL of the transformation mix was spread 
onto antibiotic LB-agar plates. The cells were grown by putting the plates up side 
down at 37°C incubator. The next day, a single colony was picked and inoculated in 
250mL of LB medium containing the appropriate selective antibiotic incubate for 16 
hours at 37°C. The DNA was purified using Qiagen Plasmid Maxi Prep Kit (Qiagen 
Inc.) according to the manufacturer'protocol. DNA concentration was determined by 
UV spectrophotometry at 260nm. 
Boiling Mini Preps 
The transformation experiment was first performed using the desired DNA. 
After about 16 hours at 37°C, the colonies were observed. Then were picked and 
grown in 2mL of LB media containing the appropriate selective antibiotic for 
overnight. 2mL growth culture was transferred into an Eppendorf tube and 
centrifuged at 4000x for 5 minutes. The supernatant was then removed using 
aspirator. The cell pellets were resuspended in 100 uL of boiling mini prep solution 
(8% glucose, 5% Triton X-100, 50mM EDTA, 50mM TRIS pH 8.0, lOmg/mL 
lysozyme), and boiled for 30 seconds in a hot water bath. The lysed cells were placed 
on ice for 30 minutes, and centrifuged at 40°C for 15 minutes at 4000x g. The 
supernatant, which contained the desired plasmid DNA, was then transferred to a 




HEK-293, NIH 3T3, U2-0S, SaOS-2 cells were cultured in Dulbecco's 
modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine Serum 
(FBS) (Sigma), 1% penicillin-streptomycin (Gibco). All cell lines were maintained at 
37°C in a humidified atmosphere containing 5% C02. Sf9 cells (a kind gift from Dr. 
Lisa A. Porter, University of Windsor) were cultured in Grace's insect medium 
(Sigma) supplemented with 10% Insect Medium Supplement 10X (Sigma) and 1% 
penicillin- streptomycin (lOOug/mL) (Gibco). Sf9 cells were grown at 27°C. 
Transfection and Cell Lysis 
1.0 xl06HEK 293 cells were seeded onto 10cm tissue culture dishes. 24 hours 
later, 6ug of DNA per plate was transfected using Effectene TM (Qiagen) according 
to the manufacturer's recommendations. Approximately 16 hours post- transfection, 
cells were harvested by centrifugation at 250 x g for 5 minutes. The medium was 
removed and the cells were washed three times with lxPBS, then the cells were lysed 
with lmL ice cold lysis buffer containing Protease Inhibitor Cocktail. The lysed cells 
were allowed to sit on ice for 20 minutes, then scraped off the plates and collected in 
eppendorf tubes. The lysates were clarified by centrifuging at 3,000 x g for 20 
minutes at 4°C. 
Immunoprecipitation 
Immunoprecipitation of FLAG-tagged expression plasm ids and endogenous 
Cyclin Bl was performed by incubating approximately lmg of lysate with 1.5 ug of 
anti-Cyclin Bl (Sigma) at 4°C on a vertical rotator for overnight, then 70 uL of a 20 
% protein G-Sepharose Slurry (GE Lifesciences) was added into immunocomplexes 
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and for an hour at 4°C. When the incubation time was over, the tubes were 
centrifuged, the supernatant was removed and the beads were washed in 500 uL of 
TNT buffer three times. After the last supernatant was removed, 25 uL of 2 x SDS 
sample buffer was added and the sample was boiled at 95°C for 5 minutes, and 
subseuqntly run on an SDS-polyacrylamide gel (SDS-PAGE). 
Western Blot Analysis 
Post electrophoresis, gels were incubated in lx transfer buffer for 15 minutes at 
room temperature on a shaker. At the same time, Immobilon-P membranes were 
activated by methanol for 20 seconds and then equilibrated in lx transfer buffer for 10 
minutes. The protein was transferred from the gel to the membrane using a semi-dry 
apparatus (Biorad) at 9 volts for 35 minutes. After the transferring of the protein to the 
membrane was completed, the membrane was blocked with Tris-buffered Saline and 
Tween (TBST) containing 1% skin milk for at least 1 hour at room temperature in 
order to reduce non-specific binding sites on the membrane. Then the membrane was 
incubated with lug of the specified primary antibody in lOmL of TBST for one hour 
at room temperature. The membrane was washed three times for 10 minutes with 
TBST and subsequently incubated with the appropriate secondary antibody for 
another 1 hour at room temperature. A dilution of 1:60,000 in TBST plus 1% skim 
milk was used for the anti-mouse or anti-rabbit secondary antibodies which were 
conjugated to horseradish peroxidase (HRP) (Amersham). Then, the membrane was 
washed with lxTBST for 10 minutes and was incubated with Super Signal West 
Femto Maximum Sensitivity Substrate (Pierce) dilution for five minutes and the 
proteins of interest were visualized by chemiluminescense. 
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Stripping and Reprobing of Western Blots 
In order to detect additional proteins on the same blot, the membrane was 
incubated with stripping buffer at 50°C for 30 minutes with some agitation and then 
washed with lx TBST for 10 minutes at 50°C. The blot was then ready for re-use in 
Western blot analysis. 
Immunofluorescence 
NIH 3T3 cells were seeded onto coverslips. 24 hours later, 3T3 cells were 
transfected with GFP-Cyclin Bl and various hSak constructs using Effectene TM 
(Qiagen) according to the manufacturer's recommendations. Approximately 16 hours 
post-transfection, cells were washed twice with PBS, then fixed with 3.7% 
paraformaldehyde in PBS pH 7.4 for 12 minutes at room temperature for 12 minutes, 
and washed twice with PBS. Cells were then permeabilized with 0.1% Triton X-100 
in PBS for 2 minutes at room temperature. Followed by washed again three times 
with PBS and blocked by lx TBST containing 10% BSA for 30 minutes at 37°C. The 
blocker was removed by washing the cover slips two times in TBST and then anti-
Flag antibody (Sigma) (1:1,000) was added to cells for 1 hour at room temperature 
with incubation in the dark in a humid atmosphere. After washing three times with lx 
TBST, 1:4000 Alexa-conjugated 568 nm goat anti-mouse secondary (Molecular 
Probes) was added for 30 minutes, then washed three times with lx TBST and 
incubated with 6'-diamidino-2-phenylindole (DAPI) (O.lmg/mL) (Molecular Probes) 
for 5 minutes at room temperature, After washing the cells once with PBS, they were 
fixed with a drop of mounting medium (Molecular Probes) and analyzed under a 
fluorescence microscope. 
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Expression and Purification of Baculovirus-expressed Protein 
5xl06 SF9 insect cells were seeded in 10 cm tissue culture dishes. Cells were 
allowed to settle and stick to the bottom of dishes 60 minutes, 20uL of recombinant 
baculovirus encoding GST-Cyclin Blwas added (a kind gift from Dr.Helen Piwnica-
Worms, Washington University School of Medicine) to 2mL Grace's media (Serum 
free) and mixed gently. The media was removed from settled insect cells. 2mL virus 
solution was added to the cells and rocked gently to disperse. The cells were 
incubated at room temperature for 60 minutes. After 60 minutes, 8mL Grace's 
complete media was added and incubated at 27°C for five days. Then the cells were 
harvested by gently pipetting two times to suspend as many cells as possible, transfer 
to sterile 15mL centrifuge tube and centrifuged at 2,500 rpm for 5 minutes. The cell 
pellet was resuspended in 300uL ice-cold insect cell lysis buffer containing 
reconstituted protease inhibitor cocktail. Cells were lysed on ice for 20 minutes. 
Lysate was centrifuged at 13,000 x g for 20 minutes at 4°C. The clear supernatant was 
added to Glutathione Sephrose Beads (GE) prepared according to manufacturer's 
protocol. The purification was performed as previously described. 
Cloning His-Gadd45a Construct 
His-Gadd45a plasmid was cloned using Creator™ DNA Cloning Kits. It uses 
Cre-loxP site to transfer Gadd45a from a Donor Vector plasmid to an Acceptor 
Vector containing His-tag (Figure 4). 
Firstly, the Creator reaction mixture was prepared as follows: 
200 ng Donor Vector 
200 ng Acceptor Vector 
2 ul 1 OX Cre Reaction Buffer 
38 
2 jil 10XBSA(lmg/ml) 
1 ul Cre Recombinase 
Add deionized H20 to bring volume up to 20 u.1. Then the Creator reaction 
mixture was incubated at room temperature (22-25°C) for 15 min and stopped by 
heating tube at 70°C for 5 min. 1 ul of reaction mixture was transformed into 
competent cells. Cells were grown at 37°C for 60 min in LB. 100 ul of transformation 
was plated on a LB-agar plate containing 30ug/ml chloramphenicol, and 7% sucrose 
(w/v) and Incubated overnight. The next day, the plate contained a mixture of larger 
colonies and smaller colonies. Pick larger colonies for screening by colony PCR using 
primers (PCP-1 and PCP-2) which only amplify across a recombination juncture. The 
PCR reaction was set up as follows: 
18.5 jil PCR-Grade Water 
2.5 JJJ 1 OX TITANIUM Taq PCR Buffer 
1 ul Creator Reaction Mixture 
1 |il PCP-1 Primer (10 uM) 
1 Hi PCP-2 Primer (10 uM) 
0.5 ul 50X dNTP Mix (10 mM ea. of dATP, dCTP, dGTP, dTTP) 
0.5 ul 50X TITANIUM Taq DNA Polymerase 
25 ul Total volume 
Primer PCP-l: 5'-GCTCACCGTCTTTCATTGCC-3' 




Figure 4. Flow chart of Cloning His-Gadd45a construct using the Creator™ 
DNA Cloning System. The Creator System uses Cre-loxP site-specific recombination 
to catalyze the transfer of a target gene Gadd45a from a Donor Vector plasmid to an 
Acceptor Vector, a plasmid containing His-tag. 
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Expression and Purification of His Fusion Proteins 
E. coli BL21 cells were transformed with the His-Gadd45a plasmid. A single 
transformed colony was picked and inoculated in 200mL of LB medium 
supplemented with 100 ug/mL of ampicilin and 34ug/mL chloramphenicol for 
overnia ht at 37°C with vigorous shaking. The following day, the 100 mL starter 
culture was added to 500 mL of LB medium and grown at 37°C until the OD6oo was 
upon 0.6. Then expression was induced with 250 uL of 0.5 mM IPTG (Fisher). After 
the cultures were grown for an additional 4 hours at 37°C, cells were harvested by 
centrifugation at 10,000 x g for 30 minutes at 4°C. Cell pellets were resuspended in 20 
mL cell lysis buffer and incubated for 20 minutes on ice, cells were then sonicated on 
ice 10 times for 10 seconds until the cloudy cell suspension becomes translucent. The 
lysate was centrifuged at 10,000 x g for 30 minutes at 4°C. The supernatant was added 
to the HiTrap Chelating HP (Amershan Biosciences) and processed according to the 
manufacturer's protocol. The flow rates were lmL/min to allow the protein to bind to 
the column. Then the His elution buffer containing 5-50 mM imidazole were added to 
column and the eluted protein was collected in lmL fractions. The fusion protein was 
then seperated on 12% SDS-PAGE gel and visualized by both coomassie blue 
staining and Western blot analysis. 
In Vitro Kinase Assay 
In order to determine whether CyclinBl is a substrate of Sak, an in vitro kinase 
assay was performed. First, Flag-hSak, Flag-T170D and Flag-K41M expression 
plasmids were transiently transfected into HEK-293 cells. The cells were lysed 24 
hours post transfection and the cell lysate was incubated with 1 ug anti- Flag antibody 
at 4 °C for 45 minutes. Then, 80uL of 20% protein G-sepharose slurry (GE 
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Lifesciences) was added to each sample and incubated at 4 °C for 45 minutes. The 
immunocomplexes were washed once with 500mM TNT wash buffer, once with 
150mM TNT wash buffer, twice with 150mM TNT wash buffer containing 500mM 
of LiCl and once with kinase buffer. The immnocomplexes were resuspended in 20 
uL of kinase buffer, 2.5uL of cold ATP and 4ug of the GST-Cyclin Bl protein. The 
kinase was started by the addition of lOuCi [y-32P] (Amersham Biosciences) and the 
samples were then incubated at 30°C for 35 minutes. Following that, 6uL of 6x SDS 
loading buffer was added to stop the reaction. Samples were boiled for 5 minutes and 
then analyzed by SDS PAGE gel, then the gel was transferred to a PVDF membrane 
as previously described. The membrane was then incubated overnight in the dark with 
a phosphoimager in order to visualize phosphorylation band of protein. Following 
this, the membrane was probed with an anti-Flag antibody in order to detect the 
immunoprecipitated proteins. The sane blot was subsequently probed with an anti-
Cyclin Bl antibody to confirm equal loading of the protein. 
Preparation of Protein for Mass Spectroscopy 
In order to extract the protein for mass spectroscropy, the coomassie stained 
bands of interest were excised from the gel and placed in siliconized microtubes. 
They were then incubated in 100 uL of destain solution and incubating for 35 minutes 
at 37 °C, shaking at 225 RPM. This procedure was repeated twice, followed by 
repeated changes of 100% acetonitrile to dehydrate the excised gel until it became 
opaque. The pieces were then lyophilized by Speed Vac for 20 minutes to ensure that 
the excised gel was completely dried. 
The dehydrated bands were then rehydrated in trypsin digestion buffer 
containing 13ng/uL promega modified trypsin and incubated on ice for 30 minutes. 
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After this period, an addition 20 uL of 50 mM ammonium bicarbonate was added to 
the gel pieces. Subsequently, the tubes were sealed with parafilm and incubated in a 
shaker at 37 °C overnight. The following morning, the samples were briefly vortexed 
and the remaining gel pieces spun down by centrifugation. The supernatant 
containing the extracted peptides was collected and transferred to a fresh siliconized 
microtube containing 5 uL of 5% Formic Acid. In order to maximize the amount of 
peptide extraction, 200 uL of 60 % acetonitrile and 1% Formic Acid were added to 
the remaining gel pieces and allowed to incubate at 37 °C for 45 minutes. This step 
was repeated an additional time. The gel pieces were then vortexed, spun down and 
the supernatant was collected and added to the peptides collected and placed in the 
siliconized microtubes. These pooled samples were then concentrated by subjecting 
them to the Speed Vac until only 10 uL of supernatant remained. Then Zip-Tip 
procedure was performed for desalting peptides. Firstly, the Zip-Tips (Eppendorf AG) 
were equilibrated by aspirating 10 uL wetting solution (60% Acetonitrile in 1% 
Formic Acid) into tips and dispensing to waste for 5 times, then peptides were bound 
to Zip-Tip by aspirating and dispensing 20 cycles and 10 uL of washing solution (1% 
Formic Acid) was aspirated and dispensed to waste for 10 times. 10 uL of elution 
solution (60% Acetonitrile in 1% Formic Acid) was added into Eppendorf 
microcentrifuge tube and aspirated and dispensed through Zip-Tip at least 20 times 
without introducing air. Then, the desalted peptides were purified by using the 
SigmaPrep. Spin Columns (Sigma). Firstly, 80 uL of the PHOS-Select affinity gel 
(Sigma) was added into the column and washed by 500uL of wash / equilibration 
buffer (250mM Acetic acid, 30% Acetonitrile) for 3 times. Followed by adding 100 
uL sample (9 uL of trypsin digested peptides in 60% Acetonitrile, 1% Formic Acid 
and 17.5M Acetic acid) into gel and the samples were incubated for 30 minutes at 
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room temperature. The spin columns were placed in collection tubes which were 
centrifuged at approximately 3000 rpm for 30 seconds, and then the resin was washed 
by 500uL wash / equilibration buffer (250mM Acetic acid, 30% Acetonitrile) and 
500uL of HPLC H20. The peptides were first eluted by 100 uL of 400mM of 
Ammomium Hydrotide, then eluted by lOOuL of 400mM of Acetic acid and 25% 
Acetonitrile. Then Zip-Tip procedure was performed again for salt reduction which 
may improve mass signals. luL of each sample was spotted directly on a MALD1 
plate and subjected to mass spectroscopy. 
UV Damage 
In order to investigate the effect of DNA damage on Sak protein expression 
levels, U2-OS and SaOS-2 cells plated in 100-mm dishes were rinsed with PBS and 
irradiated with ultra-violet radiation using a Stratalink UV crosslinker (Stratagene) at 
a dose of 10 mJ/cm2. After cell exposure to UV radiation, fresh medium was added in 
plates, and the cells were cultured in the incubator and cells were collected at the 




Sak Interacts with Cyclin Bl 
Based on the observation that Plkl phosphorylates Cyclin Bl and induces its 
nuclear entry, we tested the possibility of an interaction between Sak and Cyclin Bl 
by a co-immunoprecipitation (Co-IP) based approach. Specifically, HEK-293 cells 
were transiently transfected with various Flag-tagged Sak constructs Flag-hSak (wild-
type human Sak), Flag-hT170D (kinase active form of Sak), Flag-hK41M (kinase 
dead form of Sak) and Flag-YVHl (a negative control) (Figure 6). 16 hours post 
transfection, the expression of the Flag constructs were detected by Western blot 
analysis with anti-Flag antibody (Figure 6A). Then, the co-ip was performed in which 
anti-Cyclin Bl antibody was used to immunoprecipitate Cyclin Bl along with any 
associated proteins. The presence of Flag-Sak fusion proteins in this complex was 
determined with an anti-Flag antibody (Figure 6B). The results indicated that Sak 
interacts with Cyclin Bl . Furthermore, this interaction was not dependent on Sak 
kinase activity as both kinase dead and active forms of Sak also co-immunoprecitated 
with Cyclin Bl. The control Flag tagged protein and Flag-YVHl was not detected, 
thus indicating that the interaction was not via the Flag epitope. 
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Figure 6. Sak interacts with Cyclin Bl. HEK-293 cells were transiently transfected 
with various Flag-tagged Sak constructs, Flag-hSak (wild-type human Sak), Flag-
hT170D (kinase active form of Sak), Flag-hK41M (kinase dead form of Sak) and 
Flag-YVHl (a negative control). (A) 16 hours post transfection, the expression of the 
Flag constructs were detected by Western blot analysis with anti-Flag antibody and 
followed by probing with an anti-GAPDH antibody to confirm equal protein loading. 
(B) Co-ip was performed in which anti-Cyclin Bl antibody was used for 
immunoprecipition with Sak and anti-Flag antibody for blotting the membrane. 
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Co-localization ofSak and Cyclin Bl to the Centrosomes 
To further confirm the interaction of Sak and Cyclin Bl, co-
iramunofluorescence analysis was performed. Cyclin Bl localizes to the cytoplasm 
during S and G2 phases, From G2 to metaphase, part of Cyclin Bl is associated with 
duplicating centrosomes (Hagting A et ah, 1998), a site which Sak is also localized 
throughout the cell cycle. These observations prompted us to investigate whether Sak 
co-localizes with Cyclin Bl in centrosome. In order to test this hypothesis, N1H 3T3 
cells were seeded on cover slips, then fixed with paraformaldehyde and permeabilized 
with Triton X-100. Followed by blocked by BSA. Then an anti-Flag antibody and 
Alexa-conjugated 568 nm goat anti-mouse secondary was added to cells separately, 
then cells were incubated with 6'-diamidino-2-phenylindole (DAPI) and analyzed 
under a fluorescence microscope. The results confirmed that Sak co-localizes with 





Figure 7. Sak co-localizes with Cyclin Bl at the centrosomes. NIH 3T3 cells were 
transfected with GFP-Cyclin Bl (Green) and various hSak constructs for 16 hours. 
The overexpressed kinase was detected with anti-Flag antibody (red). Cells were 
stained with DAPI to detect the nucleus. (A, B) No co-localization showed up in two 
negative controls. (C, D, E) Flag-Sak, Flag-T170D and Flag-K41M co-localized with 
GFP-Cyclin Bl at the centrosomes, respectively. 
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igure 8. Sak and Cyclin Bl mainly co-localize at centrosome. Histogram shows 
the percentage of co-localization between GFP-Cyclin Bl and Various hSak 
constructs at centrosome and nucleus. Data from three independent experiments, 
counting 200 cells each; error bars indicate standard deviation. 
Sak d&es not Phosphorylate Cyclin Bl In-Vitro 
The interaction between Cyclin Bl and Sak suggested the possibility that 
Cyclin Bl may be a substrate of Sak. To test this hypothesis, an in vitro kinase assay 
was performed. Firstly the GST-Cyclin Bl fusion protein was purified for use as 
substrate. To confirm the purity of the protein, SDS-PAGE was performed and the gel 
was stained by coomassie blue (Figure 9A). Immunoblotting was performed using an 
anti-Cyclin Bl antibody to further confirm the purity of the GST-Cyclin Bl protein. 
Purified GST-Cyclin Bl protein yielded a protein of 85KDa, corresponding to the size 
of the GST-Cyclin Bl protein (Figure 9B). Then HEK-293 cells were transiently 
transfected with Flag-hSak, Flag-hT170D and Flag-hK41M using Effectene TM 
(Qiagen). At 16 hours post transfection, the cells were lysed, the Flag fusion proteins 
were immunoprecipitated by incubating 500ug of protein lysate with lug of anti-Flag 
antibody. The kinase assays were performed as follows; individual 
immunoprecipitated Flag-Sak proteins were incubated with baculovirus expressed 
GST-Cyclin Bl in the presence of [y-32P] ATP (Amersham Biosciences). After 30 
minutes of incubation, SDS-PAGE was performed and the membrane was exposed 
using a phosphoimager (Perkin Elmer). In order to ensure that both substrate and Sak 
protein were present, the membrane was also probed with an anti-Flag antibody and 
anti-Cyclin Bl antibody. The results of these assays are shown in (Figure 9C-D). The 
phosphorylated bands at lOOKDa correspond to the autophosphorylation of Flag-Sak 
and Flag-T170D. Under these conditions, GST-Cyclin Bl was not phosphorylated by 
Sak. 
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Figure 9. Sak does not Phosphorylate Cyclin Bl In-Vitro. (A) The GST-Cyclin 
Bl protein was produced by infecting Sf9 insect cells with baculovirus encoding 
GST-Cyclin Bl, and then purified it using GST beads, GST- Cyclin Bl protein was 
analyzed by Coomassie blue-staining. Purified GST-Cyclin Bl protein yielded a 
protein of 85KDa, corresponding to the size of the GST-Cyclin Bl protein. (B) 
Western blot was also performed with anti-Cyclin B1 antibody to further confirm that 
the band was GST-Cyclin Bl . (C) The purified GST-Cyclin Bl protein was incubated 
with Flag-Sak in the presence of ATP, subjected to SDS-PAGE, transferred protein to 
membrane and then visualized the bands using a phosphoimager. (D) The membrane 
was then subjected to Western blot analysis with an anti-Cyclin Bl antibody to ensure 
the equal GST- Cyclin B1 protein loading. 
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Sak Interacts with Gadd45a 
Gadd45a is a nuclear protein that is induced by genotoxic and other cellular 
stresses. It has been demonstrated that Gadd45a plays important roles in growth 
control, maintenance of genomic stability, DNA repair, cell cycle control and 
apoptosis. Furthermore, deletion of Gadd45a leads to centrosome amplification and 
abnormal mitosis and Gadd45a is found to interact with Aurora-A and BRCA1. Both 
of proteins are located in centrosome, a site which Sak is also localized throughout the 
cell cycle. 
These observations prompted us to investigate whether Sak also interacts with 
Gadd45a. To test this hypothesis, HEK-293 cells were transiently transfected with 
domain specific expression plasmids for Flag tagged Sak (Figure 9). 16 hours post 
transfection, the expression of the Flag constructs were detected by Western blot 
analysis with anti-Flag antibody (Figure 10A). Then, co-immunoprecipitation of 
endogenous Gadd45a and associated proteins was performed on cellular protein 
extracts using an anti-Gadd45a antibody followed by Western Blotting using an anti-
Flag antibody (Figure 10B). The results indicated that Flag-Sak (full length), Flag-
T170D (kinase active), Flag-K41M (alternate kinase dead), Flag-154N (kinase dead), 
Flag-APb (lacking polo-box domain), and Flag-Rl (cryptic polo-box domain) were all 
associated with Gadd45a. Furthermore, we did not detect an interaction between Flag-
Pb (polo-box domain) and Gadd45a indicating that the polo-box region of Sak was 
not necessary or sufficient for this interaction to occur. These results establish that 
Sak interacts with Gadd45a and the cryptic polo-box domain is sufficient for the 
intercation. 
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Figure 10. Sak interacts with Gadd45a. (A) HEK-293 cells were transiently 
transfected with expression plasmids for Flag-Sak domain specific constructs. 16 
hours post transfection cells were lysed. Whole cell lysates were immunoblotted with 
an anti-Flag antibody to determine the levels of Flag-tagged proteins, followed by 
probing with an anti-GAPDH antibody to confirm equal protein loading. (B) 
Immunoprecipitation was performed using an anti-Gadd45a antibody on prepared 
lysates and western blotting was performed using an anti-Flag antibody. Full length 
Sak, kinase dead Sak (K41M), kinase active Sak (T170D), APb-Sak (deletion of polo-
box domain of Sak), an alternate kinase dead Sak (D154N) and cryptic-polo-box 
domain (Rl) all co-immunoprecipitated with endogenous Gadd45a. The polo-box 
domain (Pb) was not observed. Whole cell lysates of non-transfected cells and a 
transfected construct encoding Flag-YVHI protein served as negative controls. 
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Sak Phosphorylates Gadd45a In-Vitro 
The interaction of Gadd45a and Sak suggested the possibility that Gadd45a 
may be a substrate of Sak. Therefore, in vitro kinase assays was performed (Figure 
11). First His-Gadd45a plasmid was cloned using Creator™ DNA Cloning Kits. To 
test whether the plasmid is successful, a PCR was set up using primers (PCP-1 and 
PCP-2) which only amplify across a recombination juncture. PCR band showed up at 
350bp indicating that the plasmid may be successful (Figure 11A). Then the plasmid 
was sequenced by ACGT corp and compared to wildtype Gadd45a, The result showed 
that the plasmid is His-Gadd45a (Figure 1 IB). Then the His-Gadd45a fusion protein 
was produced in bacteria using IPTG and purified using His affinity column. To 
confirm the purity of the protein, SDS-PAGE was performed and the gel was stained 
with coomassie blue (Figure 11C). Immunoblotting was performed using an anti-
Gadd45a antibody to further confirm the purity of the His-Gadd45a protein. Purified 
His-Gadd45a protein yielded a protein of 30KDa, corresponding to the size of the 
His-Gadd45a protein (Figure 11D). In-vitro kinase assay was performed using the 
purified His-fusion Gadd45a. HEK 293 cells were transfected with Flag-hSak, Flag-
hT170D and Flag-hK41M and immunoprecipitation was performed using an anti-Flag 
antibody. The bacterially produced His-Gadd45a protein was incubated with the Flag-
Sak immunoprecipitated constructs in the presence of [y-32P] ATP (Amersham 
Biosciences), then SDS-PAGE was performed and membrane was exposed using a 
phosphoimager (Perkin Elmer) (Figure HE). Subsequently, the membrane was 
probed with an anti-Flag antibody and anti-Gadd45a antibody to confirm the equal 
protein loading (Figure HE). The result showed that His-Gadd45a is phosphorylated 
by wildtype Flag-Sak and kinase active Flag-T170D, but not phosphorlated by kinase 
dead Flag-K41M. The phosphorylated bands at lOOKDa correspond to the 
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autophosphorylation of wildtype Flag-Sak and kinase active Flag-T170D. The result 
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Figure 11. Sak Phosphorylates Gadd45a In-Vitro (A) His-Gadd45a construct was 
cloned and A PCR was set up using primers (PCP-1 and PCP-2) to test His-Gadd45a 
construct. PCR amplified product band showed up at 350bp. (B) The His-Gadd45a 
plasmid was sequenced by ACGT corp and compared to wildtype Gadd45a. (C) His-
Gadd45a protein was expressed in bacteria using IPTG. The fusion protein was 
purified using His affinity column and SDS PAGE was performed. Purification 
resulted in a 30KDa band corresponding to His-Gadd45a protein at Coomassie blue-
staining gel. (D) Western blot was also performed using an anti-Gadd45a antibody to 
ensure the observed bands were His-Gadd45a protein. (E) Bacterially produced His-
Gadd45a was incubated with the Flag-Sak immunoprecipitated constructs in the 
presence of [y-32P] ATP (Amersham Biosciences), then SDS-PAGE was performed 
and membrane was exposed using a phosphoimager (Perkin Elmer). (F) The 
membrane was subjected to Western blot analysis with an anti-Flag antibody to 
ensure transfection efficiency, also using an anti-Gadd45a antibody to ensure equal 
protein loading. 
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Sak Phosphorylates TyrlSl on Gadd45a 
In order to identify the phosphorylation site of Sak on Gadd45a, we employed 
a mass spectrometry based approach in collaboration with the Vacratsis lab. An in 
vitro cold kinase assay was performed, protein samples were separated by SDS-
PAGE gel, followed by coomassie blue staining (Figure 12A) and the particular 
band(s) of interest were excised from the gel, and then digested with trypsin. The 
extracted peptides were spotted directly on a MALDI plate and subjected to Mass 
Spectroscopy. The Gadd45a phosphopeptide peak was identified by MALDI-TOF 
mappings at 1840 m/z (Figure 12B) and the phosphorylation specific peptides of 
Gadd45a are YMDQWVPVINLPER (Figure 12C). Then MALDI-PSD analysis of the 
phosphorylation specific peptides was performed. The sequence of this peptide 
enabled identification of the phosphorylated residue at Tyrl51 within Gadd45a 
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Figure 12. Sak phosphorylates Tyrl51 on Gadd45a. (A) An in vitro cold kinase 
assay was performed with the immunoprecipitated Flag-Sak protein, the purified His-
Gadd45a protein and cold ATP, protein samples were separated by SDS- PAGE gel, 
followed by coomassie blue staining. (B) MALDI-TOF spectrum of His-Gadd45a 
tryptic digest. Bacterially expressed His-Gadd45a was subjected to kinase assay with 
Flag-Sak, expressed and immunoprecipitated from Hek 293T cells. The peak at 1307 
m/z corresponds to Gadd45a peptide LGSFLDHSFGAR. The peak at 2212 m/z is 
common trypsin proteolysis peak. The peaks at 1761 m/z and 1840 m/z are separated 
by +80 Da, thus suggesting modification by phoshorylation. Phosphopeptide peak at 
1840m/zis marked with asterisk and shifted by 80Da (HP03 = 80 Da) relative 
to predicted unphosphorylated peptide peak at 1761 m/z. (C) MALD1-PSD 
spectrum of singly charged parental ion at 1840 m/z. The sequence of this peptide 
enabled identification of the phosphorylated residue at Tyrl51 within Gadd45a. 
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Downregulation ofSak Expression in Response to UV Irradiation is p53-dependent 
Sak was identified as a p53 target gene (Swallow et al., 2005) and 
transcriptionally repressed by p53. Furthermore, Sak mRNA levels decrease in 
response to DNA damage in a p53-dependent manner (Li et al., 2005). So the 
endogenous Sak protein expression levels in response to UV irradiation were 
investigated in order to determine the effect of DNA damage on Sak protein 
expression levels. U2-OS and SaOS-2 cells were irradiated with ultra-violet radiation, 
then collected at the indicated time. The Sak protein levels were quantified by 
Western blotting analysis. 
The results showed that endogenous Sak expression was significantly repressed in 
response to UV damage in U2-OS cells (wildtype p53) (Figure 13), whereas no 
significant change in Sak protein expression was observed in SaOS-2 cells (p53-null) 
(Figure 14). The results suggested that downregulation of Sak expression in response 
to UV irradiation is p53-dependent. 
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Figure 13. UV radiation decreases Sak protein expression levels in the U2-OS 
cells. (A) The U2-OS cells were exposed to UV irradiation and lysed at the indicated 
time points. The endogenous Sak protein expression levels were quantified by 
Western blotting analysis with anti-Sak antibody. Lysate were probed with an anti-
GAPDH antibody as a loading control. (B) Compared to no UV damage, the 
endogenous Sak protein expression levels have no change at 5 and 30 minutes after 
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Figure 14. The endogenous Sak protein expression levels remain constant in 
SaOS-2 cells. (A) The SaOS-2 cells were exposed to UV irradiation and lysed at 
indicated time points. The endogenous Sak protein expression levels were quantified 
by Western blotting analysis with anti-Sak antibody. Lysate were probed with an anti-
GAPDH antibody as a loading control. (B) Compared to no UV damage, the 
endogenous Sak protein expression levels remain constant in SaOS-2 cells after UV 




Sak interacting partners 
Plks are a conserved subfamily of Ser/Thr protein kinases that play pivotal 
roles in regulating various cellular and biochemical events at multiple stages of cell 
cycle progression (Glover et al., 1998; Nigg, 1998; Dai et al., 2003). They regulate 
cell cycle progression, including centrosome duplication, DNA damage response, 
Golgi dynamics, mitotic entry, spindle assembly and cytokinesis. 
Sak was the last member of the human Plk family to be identified. Sak has 
been implicated in playing a role in centriole biogenesis (Habedanck R et al., 2005) 
and has been implicated in playing a role during mitosis (Fode et al. 2004; Hudson et 
al. 2001). Both Sak levels and localization change throughout the cell cycle with Sak 
mRNA levels relatively low in both GO and early-to-mid-Gl phase cells, an increase 
in S and G2 and peaking in M phase. Sak homozygous null mice are embryonic 
lethal at E7.5 with a marked increase in mitotic and apoptotic cells (Hudson et al 
2001) and Sak haploinsufficiency causes mitotic infidelity and carcinogenesis (Ko et 
al, 2005). Sak heterozygous mice are fertile. However at age 18-24 months Sak 
heterozygous mice have an increased incidence of developing liver and lung cancers 
when compared to wild-type mice. While there is an increasing body of evidence for 
phenotypes associated with Sak function, the exact functions or specifically its 
molecular targets remain largely unknown. The purpose of my research was to 
identify/characterize Sak's interaction with several key cellular proteins with the goal 
of helping us further understand the essential role of Sak in the cell cycle. 
72 
The interaction between Sak and Cyclin Bl 
Previous studies have found that Plkl interacts with and phosphorylates 
Cyclin Bl thus inducing Cyclin Bl ' s nuclear entry (Toyoshima-Morimoto F et al., 
2001). This is proposed to be essential for the induction and coordination of the 
initiation of mitosis (Toyoshima-Morimoto et al, 2001). Similar to Sak, Cyclin Bl 
localization changes during the cell cycle. The protein is in the cytoplasm during S 
and G2 phases where a subpopulation associates with microtubules. Cyclin Bl 
accumulation in the cytoplasm up to metaphase upon which time it translocates to the 
nuclems. Furthermore a subpopulation of the protein associated with duplicating 
centrosomes (Hagting A et al, 1998), a site which Sak is also localized to. These 
observations prompted us to investigate whether Sak also interacts with Cyclin Bl. 
Interestingly through co-immunoprecipition and co-localization experiments, we 
found that Sak both physically interacts with Cyclin Bl and co-localizes with it at the 
centrosome. Cyclin Bl is a protein that binds to CDK1 to form a complex called MPF 
(mitosis promoting factor), MPF is activated by phosphatase Cdc25C in M phase, and 
then triggers mitosis. So Cyclin Bl is a necessary protein for mitosis entry. The 
finding suggests that Sak may play a novel role in mitosis entry through binding 
Cyclin Bl. 
The interaction of Sak with Cyclin Bl suggests that Cyclin Bl may be a 
substrate of Sak. This is supported by a recent study by Leung et al 2006 in which a 
putative phosphorylation target motif for Sak substrates was proposed to be 
[IFYLW]-{ILV}-[ST]-[YVFLICA]-[YVFLICA]-X-[PIFYLW] (Leung GC et al, 
2006). Using Expasy software, we found that the Cyclin Bl protein includes a match 
for the consensus phosphorylation site of Sak substrates. However, after numerous in-
vitro kinase assays, we were unable to demonstrate the Sak phosphorylates Cyclin Bl. 
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There are several possible explanations for our inability to observe Cyclin Bl 
phosphorylation. The simplest is that my observations are correct and Cyclin Bl is not 
a substrate of Sak. The possibility is that the observed association serves to place key 
proteins including Sak in close proximity. For example, Cdc25C is a phosphatase 
which can activate the Cyclin B/Cdkl complex by dephosphorylation of Cdkl at 
Thrl4 and Tyrl5 at end of G2 phase, thus triggering G2/M transition. This association 
may require the presence of Cyclin Bl in order to place Sak, Cdc25C and possibly 
other proteins together. Like Sak and CyclinBl, Cdc25C is also localized to 
centrosomes (Busch C et al, 2007). In this scenario the centrosome may function as a 
site of integration for the proteins that trigger mitosis. 
Another possible explanation is that Sak may phosphorylate Cyclin Bl under 
some special condition, for example genotoxic or DNA damage. Sak has been found 
to phosphorylate Chk2 in vitro, however the phosphorylation of Chk2 by Sak is 
abolished in response to UV (S. Petrinac, MSc thesis, 2007), which suggests DNA 
damage can alter the activity of Sak. Therefore, it will be interest to determine 
whether Cyclin Bl is phosphorylated by Sak in response to UV radiation or some 
other genotoxic stress. Still another alternative scenario is that, Sak may require the 
presence of other proteins, which together form a complex that regulates Sak activity 
towards Cyclin Bl . Their functions may include changing the conformation of the 
Sak protein or possibly the substrate Cyclin Bl itself in a manner that exposes the 
targeted residues. 
Sak interacts with andphosphorylates Gadd45a 
Gadd45a, growth arrest- and DNA damage inducible gene, is involved in 
control of centrosome duplication and maintenance of genomic stability. Deletion of 
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Gadd45a leads to centrosome amplification, abnormal mitosis and aneupioidy. 
Furthermore, Gadd45a is found to physically interact with Aurora-A and BRCA1 
(Shao SJ et al, 2006) that also localize to the centrosome. These observations 
prompted us to investigate a possible interaction between Sak and Gadd45a. In order 
to test this hypothesis, a co-immunoprecipitation experiment was performed using an 
anti-Gadd45a antibody followed by Western blotting using an anti-Flag antibody. The 
results indicated that wild type, kinase active and kinase dead forms of Flag-Sak all 
associated with Gadd45a. We found no association between the Sak polo-box domain 
and Gadd45a. The polo-box regions of Plkl-3 have been implicated as 
phosphopeptide substrate binding motifs that play a role in both substrate recognition 
and localization of these proteins (Lowery DW et al, 2004J. A truncated Sak protein 
that lacked the polo box was still able to associate with Gadd45a. Interestingly, the 
cryptic polo box region, Rl was sufficient for the interaction. 
The interaction between Gadd45a and Sak suggested the possibility that 
Gadd45a may be a substrate of Sak. Therefore, we tested the ability of Sak to 
phosphorylate bacterially expressed and affinity purified His-Gadd45a fusion protein 
using an in vitro kinase assay assay. The results demonstrate that Gadd45a is a 
substrate of Sak as both wild type and kinase active forms of Sak were able to 
phosphorylate Gadd45a. Our results are also consistent with the finding that the polo-
box domain of Sak may not function as a substrate docking site (Lowery DW et al, 
2005). The possibility exits that the cryptic polobox may fulfill this function. Future 
experiments would be necessary to determine this possibility. 
Implications of the interaction of Sak and Gadd45a 
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Gadd45a is nuclear protein that is induced by genotoxic and certain other 
cellular stresses, including UV radiation, methyl methanesulfonate, and ionizing 
radiation. It is involved in growth control, maintenance of genomic stability, DNA 
repair, cell cycle control, and apoptosis. A previous study found that mouse 
embryonic fibroblasts derived from Gadd45a knock-out mice exhibit centrosome 
amplification and abnormal cytokinesis (Hollander M C et al., 1999), suggesting that 
Gadd45a may play a critical role in the maintenance of centrosome stability. Gadd45a 
is also found to be transcriptionally activated by p53 (Kastan MB et al, 1992), which 
has been implicated in the maintenance of genomic stability and regulation of 
centrosome duplication. Furthermore, Gadd45a was demonstrated to interact with 
Aurora-A, strongly inhibit its kinase activity and antagonize Aurora-A-induced 
centrosome amplification (Shao SJ et al., 2006). Sak is also involved in maintenance 
of centrosome stability. Both gain- and loss-of-function experiments demonstrate that 
Sak is required for the precise reproduction of centrosomes during the cell cycle. 
However, the exact mechanism of how Sak play the role in centrosome duplication 
remains unclear. Our finding that Sak phosphorylates Gadd45a provides a novel 
mechanism that Sak might regulate centrosome stability probably via its effect on 
Gadd45a activity. Further studies are required to elucidate the relationship between 
Sak and Gadd45a in centrosome duplication in more detail. A broader understanding 
of Sak- regulated signaling pathways in maintaining centrosome stability and genomic 
fidelity will be invaluable. 
Sak phosphorylates TyrlSl on Gadd45a 
Protein phosphorylation plays a vital role in the cellular processes. Many 
signaling transduction pathways were formed by phosphorylation and 
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dephosphorylation. Phosphorylation usually occurs on serine, threonine, and tyrosine 
residues in eukaryotic proteins and phosphorylation of any site can change a protein' 
stability, activity and cellular localization. Therefore, characterizing the putative 
targets of Sak on Gadd45a will be useful in shedding light on Sak function. 
Like many other kinases, the polo-like kinase family is also regulated by 
phosphorylation. The four mammalian family members share overlapping functions, 
with some overlap in target proteins and the residues targeted. Additionally, they also 
phosphorylate unique residues within common substrates as well as unique substrates. 
Recently, Johnson et al identified the predominant consensus sequence from the set of 
substrates identified for each Plk member. The results indicate the consensus substrate 
sequences for Sak include a basic residue at -3 (37%), an acidic residue at -2 (50%), 
Tyr or hydrophobic {V) at +1 (47%) and +2 (89%), and Ser/Thr (42%) or Ala (26%) 
at +4. While this motif like that of leung et al, 2007 also predicts phosphorylation of 
Cyclin Bl, which we didn't observe, it does not predict that Gadd45a as a potential 
substrate. The interaction of Sak and Gadd45a prompted us to attempt to determine 
the phosphorylation site of Sak on Gadd45a. Using and in vitro kinase assay and a 
mass spectrometry based approach, the preliminary results suggested that the specific 
phosphorylation peptides for Gadd45a is Tyrl51 within the following peptide 
YMDQWVPVINLPER (see Figurel2C). Sak kinase domain resembles a 
serine/threonine kinase. However, the active site loop of Sak more closely resembles 
that of a tyrosine kinase. Therefore the possibility exists that Sak is a dual specificity 
kinase be able to phosphorylate Ser/Thr and Tyr. 
Sak expression levels decrease after UV irradiation 
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Plks regulate multiple processes in normal cell cycle progression and play key 
roles in DNA damage checkpoint pathways. Extensive research has demonstrated that 
Plks are important mediators for various cell cycle checkpoints that monitor 
centrosome duplication, DNA replication, formation of bipolar mitotic spindle, 
segregation of chromosomes, and mitotic exit, thus protecting cells against genetic 
instability during cell division (Nigg, 1998; Dai et al., 2002; Barr et al., 2004). Plkl 
expression level is inhibited in response to DNA damage. The DNA damage-induced 
inhibition of Plkl appears to be mediated by blocking its activation because 
expression of activation mutants of Plkl can override the G2/M arrest induced by 
DNA damage (Smits et al., 2000). In addition, Plkl can phosphorylate and inactivate 
p53, the inhibition of Plkl in response to DNA damage leads to the activation of p53 
which plays an important role in maintaining genomic fidelity by controlling cell 
cycle checkpoints and apoptotic process following cell exposure to genotoxic stress 
(Levine, 1997). In response to DNA damage, Plk2 and Plk3 are activated, suggesting 
that Plks have different roles in checkpoint control (Xie et al., 2001). Furthermore, 
Plk3 also physically phosphorylates and activates p53 during DNA damage, thus the 
activation of Plk3 in response to DNA damage leads to the activation of p53 (Ando et 
al., 2004). Sak has also been implicated in DNA damage response pathways. Sak was 
identified as a p53 target gene (Swallow et al., 2005) and transcriptionally repressed 
by p53. Furthermore, Sak mRNA levels decrease in response to DNA damage in a 
p53-dependent manner (Li et al., 2005). Since Sak levels, as well as its relationship 
with its interacting partners, may be effected by DNA damage, we were interested in 
examining the effect of UV irradiation on endogenous Sak protein expression levels. 
Commercial antibodies that recognize endogenous Sak protein have only recently 
become available. Sak protein expression was significantly repressed in response to 
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UV irradiation in p53-wildtype U2-OS cells, consistent with the decrease of Sak 
mRNA levels in response to DNA damage. To further demonstrate that this was a p53 
mediated event we also tested Sak protein levels after UV irradiation of a p53 null cell 
line, SaOS-2. SaOS-2 cells were derived from a human osteogenic sarcoma. As 
expected, no significant change in Sak expression level was observed in SaOS-2 cells. 
Taken together, the results strongly suggested that downregulation of Sak expression 
is p53-dependent. 
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Appendix A: Solutions 




















5g yeast extract 
lOgNaCl 
Adjust pH to 7.0 and autoclave 
LB-AMP Plates (1L) 
1 Og tryptone 









500mL Dulbecco's Modified Eagle's Medium (DMEM) 
50 mL(10%) Fetal Bovine Serum 
5mL (1%) Penicillin/Streptomycin 
5mL (1%) Amphotericin B 
500 uL Gentamycin 
500mL Grace' Insect Medium 
50mL(10%) Insect Medium Supplement 10X 







pH to 7.4 
Lysis Buffer 
50mM Tris-HCl pH 7.4 
150mMNaCl 
ImMEDTA 
1% Triton X-100 
1 protease inhibitor tablet (Roche) was added to every lOmL of buffer 
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Western Blotting 




0.1% Triton X-100 
50 mMTris-HCl pH 7.4 
150mMNaCl 
6 X SDS-PAGE sample buffer (lOmL) 
1M Tris pH 7.5 
3.0mL 100% glycerol 
lgSDS 
lOOmg bromophenol blue 






3.03g Tris base 
14.4g glycine 
2000mL methanol 






lOmL 10%(w/v) SDS 
6.25mL 0.5M Tris-HCl (pH=6.7) 
342ul Beta-Mercaptoethanol 
Filled to 50 mL with ddH20 
Fix Solution 
Coomassie Blue Stain 
0.2%(w/v) Coomassie Blue 
7.5% Glacial Acetic Acid 
50% Ethanol 
Destain Solution 







Adjust pH 7.0 
Add ddH20 to lOOmL and filter though 0.45u filter 
GST- Protein Purification buffers 
Cell Lysis Buffer 
50 mM Tris pH 7.5 
lOOmMNaCl 
O.lmMEDTA 
0.1% Triton X-100 
2mMDTT 




50mMTris pH 8.0 
lOmM Glutathione 




50mM Tris pH7.5 
Kinase Buffer 





1 protease inhibitor tablet (Roche) per lOmL buffer 
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